All News

A report card published by the National Organization for Rare Disorders issued grades to each state for 7 categories of rare disease policies.

Articles on physicians with business degrees, a popular diabetes drug, and alcohol as an antidepressant may not seem to have a lot in common, but they were popular on social media in 2016.

The expanded use for Novo Nordisk's new basal insulin comes 15 months after the initial FDA approval.

Wide price variation in hospital prices for the care that they render-up to a 2.7-fold difference-is driven by the hospital's market leverage, according to a new report by the New York State Health Foundation (NYSHealth).

The report seeks discussion of controversial policy solutions, including temporarily importing drugs.

Researchers at the Moffitt Cancer Center have developed a genomics model called genomic-adjusted radiation dose that can guide the radiation dose to match a tumor’s radiosensitivity.

A study by The Commonwealth Fund reports that uninsured rates have dropped in all states and fewer patients in most states say cost is a barrier to care. These improvements were observed in the years after the implementation of the Affordable Care Act.

This year, the most read articles from The American Journal of Accountable Care® explored how healthcare providers and payers have implemented innovative ideas to reduce spending while maintaining or increasing the quality of care.

What we're reading, December 21, 2016: researchers are racing to download Obamacare data before Donald Trump takes office; tens of millions of Americans import prescriptions illegally; and 4 more criminal charges in Flint water crisis.

A case study of an innovative model for wound care suggested that an integrated approach to healing wounds could result in decreased costs of care and length of hospital stay.

CMS is moving full-steam ahead with the transition to value-based care. On Tuesday, the agency announced 3 new bundled payment models in cardiac care, an expansion on the Comprehensive Care for Joint Replacement Model, and the highly anticipated new track in the Medicare Shared Savings Program.

On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery.

The findings come as CMS targets cardiac procedures in both its hospital readmission reduction program and in a bundled payment model set to take effect July 1, 2017.

Along with the peer-review research, journal articles, and news coverage, The American Journal of Managed Careâ„¢ (AJMCâ„¢) has a robust multimedia component that brings together stakeholders from across the healthcare industry to discuss important topics in the world of managed care and delve deeper into topics.

The 21st Century Cures Act mandates the creation of "one or more" intercenter institutes at the FDA. But is such a massive reorganization feasible within the FDA?

What are some effective patient engagement strategies to succeed with bundled payments?

What we’re reading, December 20, 2016: Purdue Pharma, which makes OxyContin, plans to expand its sales of the drug in foreign markets; family members blame hospital for not warning them about low-quality nursing home; a project to place blast sensors on soldiers to learn more about concussions has been discontinued.

Research published in JAMA indicates that the proportion of pregnant women who have recently used marijuana has increased significantly from 2002 to 2014.

The FDA has provided accelerated approval for rupacarib along with the first next-generation sequencing—based companion diagnostic test, for the treatment of women with advanced ovarian cancer.

The findings confirm other studies that show differences in the practice patterns between male and female physicians.

Here's a look at some of the most popular articles published in Evidence-Based Oncologyâ„¢ in 2016.

The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of different therapies.

What we're reading, December 19, 2016: how hospitals are altering routines to address rising drug costs; in Colorado, proponents of the aid-in-dying law are searching for more affordable options for the drug to induce death in terminally ill patients; and the 3000 areas in the United States with higher blood lead levels than Flint, Michigan.

The elderly population in the United States is growing significantly. People who are 80 years and older most likely need long-term care due to severe disabilities.

A recent study that conducted interviews with mainly Latino residents of agricultural communities in California found that most considered affordability, not access, a major barrier to buying healthy foods.

Two former executives at a generic pharmaceutical company have been charged with being involved with price-fixing, bid-rigging, and customer allocation conspiracies. The charges are the first that have resulted from a 2-year investigation of the generic drug industry.

A study on gender and racial inequalities in the prevalence of chronic obstructive pulmonary disease among non-smokers found that black Americans and women are at higher risk, possibly due to a combination of biological and social factors.

The number of deaths from drug overdoses in 2015 exceeded that of the prior year, which was already the highest on record.

After widespread criticism from healthcare providers, drug companies, and lawmakers, CMS has announced that it will not go forward with its proposed Medicare Part B payment program. The experimental reimbursement model was intended to reduce outpatient drug spending, but oncologists worried it would have unfairly slashed their Part B payments.

Providers who treat people with diabetes have observed the phenomenon of low-income patients who need a lot of medical care not having enough information to choose policies that meet their needs.